Cytokines and heart rate variability in patients with chronic heart failure

Ewa Straburzyńska-Migaj1, Romuald Ochotny, Anna Wachowiak-Baszyńska

  • 1I Klinika Kardiologii, Katedra Kardiologii Akademii Medycznej, ul. Długa 1/2, 61-848 Poznań. ewa.migaj-straburzynska@sk1.am.poznan.pl

Kardiologia Polska
|December 20, 2005
PubMed

Insights

In chronic heart failure (CHF), elevated proinflammatory cytokines like TNF-alpha receptors and IL-6 are linked to reduced heart rate variability (HRV). These findings suggest cytokines may play a role in HRV depression in CHF patients.

Area of Science:

  • Cardiology
  • Autonomic Nervous System Research
  • Immunology

Background:

  • Heart rate variability (HRV) is a key indicator of autonomic nervous system function.
  • Decreased HRV is associated with disease progression in chronic heart failure (CHF).
  • Elevated proinflammatory cytokines are present in CHF and may influence the nervous system.

Purpose of the Study:

  • To investigate the relationship between cytokine levels and HRV parameters in CHF patients.
  • To address existing controversies and limited reports on cytokines' role in CHF-related HRV reduction.

Main Methods:

  • Recruited 44 CHF patients (NYHA class I-IV) and 15 healthy controls.
  • Performed 24-hour Holter ECG monitoring for time-domain HRV analysis.
  • Measured plasma concentrations of sTNF-RI, sTNF-RII, and IL-6 using ELISA kits.

Main Results:

  • CHF patients exhibited significantly decreased HRV indices and increased cytokine levels compared to controls.
  • Observed significant negative correlations between sTNF-RI, sTNF-RII, and IL-6 levels and HRV indices (SDNN, SDANN, SDNNI) in the total study population.

Conclusions:

  • Confirmed significant negative correlations between TNF-alpha soluble receptors (sTNF-RI, sTNF-RII) and IL-6 levels and time-domain HRV parameters.
  • Further research is necessary to elucidate the causal mechanisms and the precise role of cytokines in HRV depression in severe CHF.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Factors Influencing Heart Rate01:30

Factors Influencing Heart Rate

The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
Regulation of Heart Rates01:31

Regulation of Heart Rates

The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...